Aktuelle Verpflichtungen Veränderung Datum
Akebia Therapeutics USD 162.94M 29.56M 2025-12
Alaunos Therapeutics USD 921K 153K 2025-09
Avita Medical AUD 62.68M 77K 2025-12
Dianthus Therapeutics USD 30.73M 6.88M 2025-12
Ionis Pharmaceuticals USD 783M 120.46M 2025-12
IQVIA Holdings USD 8.34B 170M 2025-12
Moderna USD 1.99B 306M 2025-12
Organon & Co USD 2.68B 117M 2025-09
Revvity USD 1.33B 108.5M 2025-12
Tectonic Therapeutic USD 9.67M 293K 2025-12
Tilray USD 259.32M 8.32M 2025-09
Viatris USD 7.09B 269.8M 2025-12
Xeris Pharmaceuticals USD 109.57M 6.63M 2025-12
Zealand Pharma A/S 664.96M 513.61M 2025-12